Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 3.33 BRL -7.24% Market Closed
Market Cap: 2.1B BRL
Have any thoughts about
Oncoclinicas do Brasil Servicos Medicos SA?
Write Note

Net Margin
Oncoclinicas do Brasil Servicos Medicos SA

1.2%
Current
1%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.2%
=
Net Income
72.4m
/
Revenue
6.1B

Net Margin Across Competitors

Country BR
Market Cap 2.1B BRL
Net Margin
1%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Net Margin
6%
No Stocks Found

Oncoclinicas do Brasil Servicos Medicos SA
Glance View

Market Cap
2.1B BRL
Industry
Health Care

Oncoclínicas do Brasil Serviços Médicos SA operates as a holding company, which engages in oncology clinics through the health care segment. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2021-08-10. The firm provides of medical services focused on Oncology. The Company, since its foundation, in addition to acting directly in the treatment of cancer patients, has dedicated itself to the study and identification of the appropriate therapy opportunities for patients and the growth trends in the sector. The firm holds interest in a number of subsidiaries, such as Centro de Quimioterapia Antiblastica e Imunoterapia SA, Centro Mineiro de Infusoes SA, and Centro Paulista de Oncologia SA.

ONCO3 Intrinsic Value
12.17 BRL
Undervaluation 73%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.2%
=
Net Income
72.4m
/
Revenue
6.1B
What is the Net Margin of Oncoclinicas do Brasil Servicos Medicos SA?

Based on Oncoclinicas do Brasil Servicos Medicos SA's most recent financial statements, the company has Net Margin of 1.2%.